Rational design of a classical swine fever C-strain vaccine virus that enables the differentiation between infected and vaccinated animals

Journal of Virological Methods

Volumn 163, Issue 2, 2010, Pages 175-185

  Kortekaas, J ^a   Vloet, R P M ^a   Weerdmeester, K ^a   Ketelaar, J ^a   van Eijk, M ^a   Loeffen, W L ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Classical swine fever virus; DIVA; Forced virus evolution; Genetic stability; Vaccine

Indexed keywords

CLASSICAL SWINE FEVER C STRAIN VACCINE; GLYCAN; GLYCOPROTEIN E2; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DRUG DESIGN; DRUG SCREENING; GENETIC STABILITY; GENETIC TRANSFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PESTIVIRUS; PRIORITY JOURNAL; PROTEIN TARGETING; RABBIT; SEQUENCE ANALYSIS; SERODIAGNOSIS; SWINE; VIRUS MUTATION;

ANIMALS; ANTIBODIES, VIRAL; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; EPITOPES; EVOLUTION, MOLECULAR; MODELS, BIOLOGICAL; MUTATION, MISSENSE; RABBITS; SEQUENCE DELETION; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRUS REPLICATION;

ANIMALIA; CLASSICAL SWINE FEVER VIRUS; ORYCTOLAGUS CUNICULUS; SUIDAE;

EID: 73049105136     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.09.012     Document Type: Article

References (37)

1. Beer M., Reimann I., Hoffmann B., and Depner K. Novel marker vaccines against classical swine fever. Vaccine 25 (2007) 5665-5670
2. Berkhout B., and Das A.T. Virus evolution as a tool to study HIV-1 biology. Methods Mol. Biol. 485 (2009) 436-451
3. Bognár K., and Mészáros J. Experiences with lapinized hog cholera virus strain of decreased virulence. Acta Vet. Acad. Sci. Hung. 13 (1963) 429-438
4. Depner K.R., Bouma A., Koenen F., Klinkenberg D., Lange E., de Smit H., and Vanderhallen H. Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows. Vet. Microbiol. 83 (2001) 107-120
5. de Smit A.J., Bouma A., van Gennip H.G.P., de Kluijver E.P., and Moormann R.J.M. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs. Vaccine 19 (2001) 1467-1476
6. de Smit A.J., van Gennip H.G., Miedema G.K., van Rijn P.A., Terpstra C., and Moormann R.J. Recombinant classical swine fever (CSF) viruses derived from the Chinese vaccine strain (C-strain) of CSF virus retain their avirulent and immunogenic characteristics. Vaccine 18 (2000) 2351-2358
7. Edwards S., Moennig V., and Wensvoort G. The development of an international reference panel of monoclonal antibodies for the differentiation of hog cholera virus from other pestiviruses. Vet. Microbiol. 29 (1991) 101-108
8. European Commission, 2003. Report on the evaluation of a new classical swine fever discriminatory test (2003/265/EC). SANCO/10809/2003. European Commission, Directorate-General for Health and Constumer Protection, Brussels.
9. Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., and Ball L.A. Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses (2005), Academic Press, an imprint of Elsevier
10. Holinka L.G., Fernandez-Sainz I., O'Donnell V., Prarat M.V., Gladue D.P., Lu Z., Risatti G.R., and Borca M.V. Development of a live attenuated antigenic marker classical swine fever vaccine. Virology 384 (2009) 106-113
11. Hulst M.M., Westra D.F., Wensvoort G., and Moormann R.J. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J. Virol. 67 (1993) 5435-5442
12. Koenig P., Lange E., Reimann I., and Beer M. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against classical swine fever virus (CSFV). Vaccine 25 (2007) 3391-3399
13. Kornfeld R., and Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54 (1985) 631-664
14. Lin M., Lin F., Mallory M., and Clavijo A. Deletions of structural glycoprotein E2 of classical swine fever virus strain alfort/187 resolve a linear epitope of monoclonal antibody WH303 and the minimal N-terminal domain essential for binding immunoglobulin G antibodies of a pig hyperimmune serum. J. Virol. 74 (2000) 11619-11625
15. Maurer R., Stettler P., Ruggli N., Hofmann M.A., and Tratschin J.-D. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV. Vaccine 23 (2005) 3318-3328
16. Moormann R.J.M., van Gennip H.G.P., Miedema G.K.W., Hulst M.M., and van Rijn P.A. Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirus. J. Virol. 70 (1996) 763-770
17. Peng W.P., Hou Q., Xia Z.H., Chen D., Li N., Sun Y., and Qiu H.J. Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of Classical swine fever virus by phage-displayed random peptide library. Virus Res. 135 (2008) 267-272
18. Phan T., Beran R.K., Peters C., Lorenz I.C., and Lindenbach B.D. Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes. J. Virol. 83 (2009) 8379-8395
19. Reimann I., Depner K., Trapp S., and Beer M. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 322 (2004) 143-157
20. Risatti G.R., Holinka L.G., Carrillo C., Kutish G.F., Lu Z., Tulman E.R., Sainz I.F., and Borca M.V. Identification of a novel virulence determinant within the E2 structural glycoprotein of classical swine fever virus. Virology 355 (2006) 94-101
21. Slootstra J.W., Puijk W.C., Ligtvoet G.J., Langeveld J.P., and Meloen R.H. Structural aspects of antibody-antigen interaction revealed through small random peptide libraries. Mol. Divers. 1 (1996) 87-96
22. Terpstra C., and de Smit A.J. The 1997/1998 epizootic of swine fever in the Netherlands: control strategies under a non-vaccination regimen. Vet. Microbiol. 77 (2000) 3-15
23. Terpstra C., and Wensvoort G. The protective value of vaccine-induced neutralising antibody titres in swine fever. Vet. Microbiol. 16 (1988) 123-128
24. Thiel H.J., Stark R., Weiland E., Rumenapf T., and Meyers G. Hog cholera virus: molecular composition of virions from a pestivirus. J. Virol. 65 (1991) 4705-4712
25. Uttenthal A., Le Potier M.F., Romero L., De Mia G.M., and Floegel-Niesmann G. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs. Vet. Microbiol. 83 (2001) 85-106
26. van Aarle P. Suitability of an E2 subunit vaccine of classical swine fever in combination with the E(rns)-marker-test for eradication through vaccination. Dev. Biol. (Basel) 114 (2003) 193-200
27. van Gennip H.G., Bouma A., van Rijn P.A., Widjojoatmodjo M.N., and Moormann R.J. Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV. Vaccine 20 (2002) 1544-1556
28. van Gennip H.G., van Rijn P.A., Widjojoatmodjo M.N., de Smit A.J., and Moormann R.J. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response. Vaccine 19 (2000) 447-459
29. van Gennip H.G., van Rijn P.A., Widjojoatmodjo M.N., and Moormann R.J. Recovery of infectious classical swine fever virus (CSFV) from full-length genomic cDNA clones by a swine kidney cell line expressing bacteriophage T7 RNA polymerase. J. Virol. Methods 78 (1999) 117-128
30. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet. Microbiol. 96 (2003) 367-384
31. van Rijn P.A., van Gennip H.G., de Meijer E.J., and Moormann R.J. Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia. J. Gen. Virol. 74 (1993) 2053-2060
32. van Rijn P.A., van Gennip H.G.P., Leendertse C.H., Bruschke C.J.M., Paton D.J., Moormann R.J.M., and van Oirschot J.T. Subdivision of the pestivirus genus based on envelope glycoprotein E2. Virology 237 (1997) 337-348
33. van Rijn P.A., Miedema G.K., Wensvoort G., van Gennip H.G., and Moormann R.J. Antigenic structure of envelope glycoprotein E1 of hog cholera virus. J. Virol. 68 (1994) 3934-3942
34. van Zijl M., Wensvoort G., de Kluyver E., Hulst M., van der Gulden H., Gielkens A., Berns A., and Moormann R. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J. Virol. 65 (1991) 2761-2765
35. Wehrle F., Renzullo S., Faust A., Beer M., Kaden V., and Hofmann M.A. Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines. J. Gen. Virol. 88 (2007) 2247-2258
36. Wensvoort G. Topographical and functional mapping of epitopes on hog cholera virus with monoclonal antibodies. J. Gen. Virol. 70 (1989) 2865-2876
37. Widjojoatmodjo M.N., van Gennip H.G.P., Bouma A., van Rijn P.A., and Moormann R.J.M. Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines. J. Virol. 74 (2000) 2973-2980